What is the ticker symbol for Prelude Therapeutics?

Prelude Therapeutics trades under the ticker PRLD on NASDAQ.

What sector does Prelude Therapeutics operate in?

Prelude Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PRLD in a portfolio?

PortView shows PRLD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Prelude Therapeutics (PRLD) Stock Analysis

NASDAQHealthcareBiotechnology

$5.55+1.09%

1-year price historyRange $0.98 – $6.63

52-week range$5.55

$0.98$6.83

What Prelude Therapeutics does

Prelude Therapeutics, Inc. is a clinical-stage precision oncology company focused on identifying and developing innovative, targeted cancer treatments for patient populations with unmet medical needs. Its pipeline includes PRT543, currently undergoing Phase 1 clinical evaluation for certain solid tumors and myeloid malignancies. Another asset, PRT811, is also in Phase 1 trials, targeting various solid tumors, notably glioblastoma multiforme. The company is additionally progressing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a powerful and highly kinome-selective CDK9 inhibitor; PRT-SCA2, which is in preclinical development for several genomically selected cancers; PRT3645, a brain-penetrant molecule that precisely and effectively targets CDK4/6; and PRT-K4, another preclinical compound for solid tumors. Founded in 2016, the firm's headquarters are located in Wilmington, Delaware.

Key metrics

Market cap

$315.98M

P/E (TTM)

-5.55

EPS (TTM)

$-1.00

Beta

0.94

Dividend yield

0.00%

Revenue / share

$0.23

50-day avg

$4.98

200-day avg

$3.56

52-week high

$6.83

52-week low

$0.98

CEO

Krishna Vaddi

ETFs linked to PRLD

Broad-market and Healthcare sector ETFs an investor holding Prelude Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how PRLD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PRLD in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Prelude Therapeutics?: Prelude Therapeutics trades under the ticker PRLD on NASDAQ.
Which exchange is PRLD listed on?: PRLD is listed on NASDAQ.
What sector does Prelude Therapeutics operate in?: Prelude Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PRLD in a portfolio?: PortView shows PRLD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.